Browse Drug Recalls
7 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 7 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 7 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Dec 31, 2025 | CHNaO Fluorescein Sodium Ophthalmic Strips, USP 1mg, packaged as a) 100-count... | Lack of Assurance of Sterility: Products have not been manufactured in conformance with current g... | Class II | Wizcure Pharmaa Private Limited |
| Dec 31, 2025 | Vista Meibo Tears Propylene Glycol 0.6% w/v Eye Drops Advanced Dry Eye Relief... | Lack of Assurance of Sterility: Products have not been manufactured in conformance with current g... | Class II | Wizcure Pharmaa Private Limited |
| Dec 31, 2025 | Vista Gonio Eye Lubricant, Hypromellose Ophthalmic Solution USP (Sterile Drop... | Lack of Assurance of Sterility: Products have not been manufactured in conformance with current g... | Class II | Wizcure Pharmaa Private Limited |
| Dec 31, 2025 | Vista Gel Hypromellose USP 0.3% w/v, Eye Drops Dry Eye Relief Lubricating Gel... | Lack of Assurance of Sterility: Products have not been manufactured in conformance with current g... | Class II | Wizcure Pharmaa Private Limited |
| Dec 31, 2025 | Vista Tears Polyethylene Glycol 400 0.4% w/v, Propylene Glycol 0.3% w/v Eye D... | Lack of Assurance of Sterility: Products have not been manufactured in conformance with current g... | Class II | Wizcure Pharmaa Private Limited |
| Dec 31, 2025 | Bio Glo Fluorescein Sodium Ophthalmic Strips USP, 300 diagnostic strips, Manu... | Lack of Assurance of Sterility: Products have not been manufactured in conformance with current g... | Class II | Wizcure Pharmaa Private Limited |
| Dec 31, 2025 | BioGlo Fluorescein Sodium Ophthalmic Strips USP, 100 diagnostic strips, Manuf... | Lack of Assurance of Sterility: Products have not been manufactured in conformance with current g... | Class II | Wizcure Pharmaa Private Limited |
Frequently Asked Questions
When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.